This study used R-language data mining to analyze patents of topical Chinese medicine for hair loss, identifying key medication patterns and ingredients in traditional formulations.
31 citations
,
January 2025 in “Journal of the American Academy of Dermatology” GLP-1 RA medications may be linked to hair loss.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” COVID-19 vaccines have been linked to an increase in hair loss conditions.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source notes that minoxidil and finasteride are the most supported treatments for androgenetic alopecia, with combination treatments like PRP showing promise, while the role of saw palmetto remains unclear.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study suggests that minoxidil and finasteride are the most supported treatments for androgenetic alopecia, with promising combination therapies like PRP, while saw palmetto's effectiveness remains unclear.
8 citations
,
January 2015 in “World Journal of Gastroenterology” This study found that hair loss is common among patients with inflammatory bowel disease, with mesalamine and anti-TNF medications associated with lower odds of experiencing hair loss.
1 citations
,
October 2024 in “Journal of Cosmetic Dermatology” This study conducted on YouTube Shorts videos found that a majority of content related to alopecia recommended treatments that could be carried out independently, such as over-the-counter medications, while professional recommendations by dermatologists comprised less than 15% of the videos but showed high viewer engagement.
December 2022 in “International Journal of Biomedicine” This review discusses the potential role of androgens in COVID-19's pathophysiology and their possible link to hair disorders, but reports no new clinical results.
January 2015 in “Indian Dermatology Online Journal” This diagnostic discussion reports that diffuse alopecia areata was identified in a patient with diffuse hair loss, based on specific histopathological features observed in a biopsy.
January 2014 in “Astrocyte” This study found that among women with diffuse hair loss, 26.2% had a history of drug intake, with antihypertensives being the most common drug group implicated.
1 citations
,
July 2015 in “The European research journal” This case report describes reversible hair loss in a patient taking aripiprazole, suggesting this side effect may be common among psychotropic medications.
9 citations
,
April 1986 in “Postgraduate Medicine” This article reviews the causes of hair loss in pediatric and adult populations, emphasizing the importance of distinguishing between primary dermatologic conditions and those related to systemic diseases, but reports no new clinical findings.
3 citations
,
January 2021 in “Skin appendage disorders” This case report describes how trichoscopy helped diagnose tinea capitis disguised as female pattern hair loss in cases of endothrix infection, highlighting its usefulness in avoiding misdiagnosis.
2 citations
,
February 2014 in “Journal of the European Academy of Dermatology and Venereology” This letter reports three cases of diffuse hair loss linked to hyperprolactinaemia but does not present new research findings.
February 2026 in “Journal of the American Academy of Dermatology” In this retrospective study, researchers found that while combination therapy of spironolactone and oral minoxidil for female alopecia commonly led to mild outpatient-manageable side effects, starting both medications simultaneously reduced hypertrichosis risk, but taking multiple blood pressure medications increased hypotensive symptoms.
This article discusses the role of women’s health nurse practitioners in diagnosing and managing female hair loss, particularly highlighting the treatment options for female pattern hair loss, which affects up to 50% of women over 50.
November 2024 in “International Society of Hair Restoration Surgery” This study investigated adverse events from low-dose systemic minoxidil in an older population with hair loss and found that 19% experienced mainly facial and body hypertrichosis, managed with interventions like dose reduction and diuretics; no serious adverse events occurred.
December 2023 in “Journal of Korean Society of Beauty Cultral Arts” This study observed that among hair loss patients in Daejeon and Chungcheong, female pattern hair loss was most common, scalp massage was the preferred management behavior, and satisfaction was above average except for lower satisfaction with folk remedies.
November 2022 in “Journal of clinical images and medical case reports” The researchers reported that COVID-induced telogen effluvium can occur after both severe and mild infections, potentially presenting earlier than other causes, and necessitates specific patient management due to its psychological impact.
This article reviews common disorders leading to hair loss in females and discusses their clinical features and management strategies, but it presents no new clinical results.
September 2016 in “Gynecology Obstetrics and Reproductive Medicine” This review outlines the diagnostic criteria and management strategies for polycystic ovary syndrome, focusing on hyperandrogenism's cutaneous manifestations, such as hirsutism and acne, and describes treatments like oral contraceptives and antiandrogens to address these issues.
63 citations
,
March 2000 in “Annals of clinical psychiatry” This article reviews the association between psychopharmaceuticals and medication-induced alopecia, noting that hair regrowth typically occurs after discontinuing or reducing the medication, while mineral supplements' effectiveness remains unclear.
8 citations
,
May 2022 in “Journal of medicine and life” This study found that telogen effluvium, a type of hair loss, was prevalent among 24% of COVID-19 patients, likely triggered by stress and medication related to the illness.
4 citations
,
August 2021 in “GSC biological and pharmaceutical sciences” This article reviews various causes of hair loss, including genetic and environmental factors, and explores different medicinal plants that may help prevent or treat hair loss.
3 citations
,
June 2005 in “Ophthalmology Clinics of North America” Follicular unit transplantation treats hair loss and restores eyebrows with short recovery and natural results.
August 2024 in “Journal of Dermatology for Physician Assistants” In this review, potential causes of COVID-19 and immunization-induced hair loss are explored, highlighting the need for early treatment and further research to clarify whether stress, viral infection, treatment medications, or nutritional deficiencies are responsible.
September 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study at Sree Ramakrishna Medical College in Tamil Nadu found that young females experiencing hair loss also report disturbed sleep, depression, and irritability, suggesting a need for increased awareness about health, nutrition, hair care, personal hygiene, and sleep among this population.
January 2021 in “International Journal of Homoeopathic Sciences” This narrative discusses various reasons for increased hair fall during the pandemic but does not present new research findings.
November 2009 in “Cambridge University Press eBooks” This review discusses the necessity for hair transplant surgeons to be well-versed in both surgical and medical treatments for various forms of alopecia, and it reports no new results.
79 citations
,
January 2000 in “Annals of Clinical Psychiatry” This review discusses the potential for mood stabilizers, antidepressants, and some antipsychotic and antianxiety drugs to induce alopecia and reports no clinical results.